VITABEST NUTRITION, INC. – Trademark Portfolio
Entity Type: 03
VITABEST NUTRITION, INC. holds 25 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 18 filings in this category. The portfolio also extends into Class 40 (Treatment & Processing) across 3 Nice Classification classes. Currently, 4 trademarks are registered and 6 are pending. Notable registered marks include VIT-BEST, BODY & SOUL, and VIT-BEST NUTRITION. The owner is based in TUSTIN, CA.
2802 DOW AVE.
TUSTIN, CA 92780
Showing of trademarks Trademarks
Trademark Classifications
VITABEST NUTRITION, INC.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations
Frequently Asked Questions
How many trademarks does VITABEST NUTRITION, INC. have?
VITABEST NUTRITION, INC. has 25 U.S. trademarks filed with the USPTO. Of these, 4 registered, 6 pending, 12 abandoned, 3 cancelled.
What trademark classes does VITABEST NUTRITION, INC. file in?
VITABEST NUTRITION, INC. files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 30 (Staple Foods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are VITABEST NUTRITION, INC.'s most well-known trademarks?
VITABEST NUTRITION, INC.'s registered trademark portfolio includes well-known marks such as VIT-BEST, BODY & SOUL, and VIT-BEST NUTRITION. These are among 4 currently registered trademarks in the portfolio.
What is VITABEST NUTRITION, INC.'s trademark registration success rate?
VITABEST NUTRITION, INC. has a 21% trademark registration rate, with 4 out of 19 resolved applications resulting in successful registration. Currently, 6 applications are pending review.